Hanny Al-samkari, Md

This study tests whether bevacizumab, a drug that blocks blood vessel growth, can reduce chronic bleeding and iron deficiency anemia in people with hereditary hemorrhagic telangiectasia (HHT). HHT causes abnormal, fragile blood vessels that bleed easily. The trial enrolled 33 adu…

This phase 2 study tests whether avatrombopag, a drug that boosts platelet production, can safely and effectively treat persistent low platelet counts caused by chemotherapy in people with gastrointestinal cancers. About 60 adults will receive either avatrombopag or a placebo. Th…